EcoDrugPlus

Thromboxane A2 Receptor

Ensembl ID : ENSACIG00000010013
Gene Symbol: TBXA2R
1 Cross references
193 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSACIG00000014709
Gene Symbol: TYMP
2 Cross references
173 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSACIG00000016229
Gene Symbol: TYMS
1 Cross references
225 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSACIG00000002010
Gene Symbol: TRHR
1 Cross references
203 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSACIG00000019764
Gene Symbol: TRHRB
1 Cross references
194 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSACIG00000014849
Gene Symbol: TLR2
2 Cross references
182 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSACIG00000008478
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSACIG00000008462
Gene Symbol: TLR8
2 Cross references
185 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSACIG00000010404
Gene Symbol: TLR2
1 Cross references
211 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSACIG00000001062
Gene Symbol: TAAR1
1 Cross references
431 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSACIG00000004473
Gene Symbol: TAAR1
1 Cross references
431 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSACIG00000001109
Gene Symbol: TAAR1
1 Cross references
396 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).